How to separate fact from fiction when you read COVID-19 news

{ object.primary_image.title }}

Anecdotes and data often appear side by side in news stories about the pandemic. And data can be interpreted in multiple ways. Here’s what to look for. With COVID-19, a news story that may be 100% accurate can still unintentionally mislead readers about the greatest threats of the pandemic. The unintended outcome results from a lesson taught to every journalism student: Use “real people” to “humanize” the news. Read Full Story

More

Are you avoiding coronavirus news? You’re not alone

{ object.primary_image.title }}

A staggering 66% say they avoid COVID-19 news because “they are primarily worried about the effect it has on their mood.” For the first several months after the COVID-19 pandemic went widespread, it seemed like people couldn’t get enough news about it. Matter of fact, traffic to the world’s top news sites surged by 54% by late March. Now, however, it appears that people are starting to avoid news sites even as the pandemic continues to spread. Read Full Story

More

Pfizer’s COVID-19 vaccine: 6 things to know

{ object.primary_image.title }}

Yes, it’s very good news—yet it’s important to keep hopes and expectations in check. Nothing is certain yet. There’s some massive news out about COVID-19—and it’s good for a change. Pfizer and BioNTech’s vaccine is reportedly successful in preventing over 90% of infections according to early data from its phase 3 study , says STAT News. Needless to say, if the data holds as the study continues, this vaccine could be the thing that turns the tide of the COVID-19 pandemic in humanity’s favor. Read Full Story

More

Moderna is testing a COVID-19 vaccine on humans. This is what they’re not telling you

{ object.primary_image.title }}

Moderna reported positive Phase I testing results for its COVID-19 vaccine and will begin Phase III testing it on 30,000 humans in two weeks. News! Moderna reported positive Phase I testing results for its COVID-19 vaccine and will begin Phase III testing it on 30,000 humans in two weeks. (Separate Phase II trials are underway.) “No matter how you slice this, this is good news,” Dr. Anthony Fauci, our national bearer of bad news, told the Associated Press. Read Full Story

More

Subscribe to our newsletter

Join our newsletter and never miss out trending marketing news.

HitcountVariables(pk=4115, ajax_url='/api/hit/ajax/', hits='3')